Cytophage Technologies Appoints James Kinley as Chief Financial Officer
I'm PortAI, I can summarize articles.
Cytophage Technologies Ltd. has appointed James Kinley as its new Chief Financial Officer, succeeding Julius Kalcevich. Kinley, who has experience in the biotech industry, will serve as a fractional CFO. Kalcevich will assist during the transition and remain available as an independent consultant.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments